AvePoint (AVPT) executive chairman Gong Xunkai sells $834,668 in stock

Published 06/11/2025, 03:14
AvePoint (AVPT) executive chairman Gong Xunkai sells $834,668 in stock

AvePoint, Inc. (NASDAQ:AVPT) Executive Chairman Gong Xunkai sold a total of $834,668 in company stock on November 3rd and 4th, according to a Form 4 filing with the Securities and Exchange Commission. AvePoint, with a current market capitalization of $3.07 billion, has seen its shares rise to $14.28 following these transactions.

The sales involved 60,000 shares of AvePoint common stock, with prices ranging from $13.80 to $13.96. Specifically, on November 3, Gong Xunkai sold 41,679 shares at $13.96 per share. Followed by another sale of 18,321 shares at $13.80 per share on November 4th. According to InvestingPro data, the stock is currently trading slightly above its Fair Value, with analyst price targets ranging from $17 to $26.

Following these transactions, Gong Xunkai indirectly owns 15,040,668 shares held by trusts and LLCs .

The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 22, 2025 .

In other recent news, Apex Treasury Corporation successfully closed its upsized initial public offering, raising $344.7 million. The offering included 34.47 million units priced at $10.00 each, with an additional 4.47 million units issued through the underwriters’ over-allotment option. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, exercisable at $11.50 per share. Meanwhile, AvePoint Inc. has garnered attention from several investment firms. Morgan Stanley initiated coverage on AvePoint with an Overweight rating, citing its alignment with Microsoft and potential in the generative AI space. B.Riley also initiated coverage with a Buy rating, highlighting AvePoint’s growth in the data backup market. Furthermore, Evercore ISI raised its price target on AvePoint from $20 to $22, maintaining an Outperform rating. These developments reflect a growing interest in AvePoint’s market positioning and potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.